Trial Profile
A phase 1, open label, randomized, fixed sequence study to evaluate the effect of multiple dose administration of grapefruit juice on the multiple dose pharmacokinetics of CP-945,598 in healthy overweight and obese subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Otenabant (Primary)
- Indications Obesity
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
- 14 Apr 2008 New trial record.